Targeting of tripartite neuron-cancer-immune cell crosstalk augments response to chemotherapy and immunotherapy. [PDF]
Jain D +31 more
europepmc +1 more source
Abstract Anti‐B cell maturation antigen (BCMA) therapies, including antibody‐drug conjugates, chimeric antigen receptor T cells, and bispecific antibodies (bsAbs), have recently revolutionized the treatment landscape of multiple myeloma. This review outlines the biologic rationale for targeting BCMA and sheds light on the mechanism of action of bsAbs ...
Enrica Manzato +5 more
wiley +1 more source
Differential perforin sensitivity drives lineage-dependent resistance to CAR T-cell killing in blood cancer cell lines. [PDF]
Hodel AW +8 more
europepmc +1 more source
Anti-BCMA CAR-NK Cells Reveal Enhanced Cytolytic and Secretory Responses Against Myeloma Cells. [PDF]
Divsalar B +3 more
europepmc +1 more source
Checkpoint-enriched T cells with retained effector-associated features are associated with disease activity in systemic lupus erythematosus. [PDF]
Santana-Sánchez P +6 more
europepmc +1 more source
Advances in miRNA-Mediated Bidirectional Crosstalk and Immune Evasion Mechanisms Between Lung Cancer Cells and CD8<sup>+</sup> T Cells. [PDF]
Zhou X, Pang T, Ge Z.
europepmc +1 more source
Engineering a dual-antigen mRNA vaccine to restore immune control in chronic hepatitis B. [PDF]
Zhang B +9 more
europepmc +1 more source
CD8<sup>+</sup> tissue-resident memory cells- do they modulate peripheral nervous system and neuroinflammation? [PDF]
Pandiyan P.
europepmc +1 more source

